+36.1%
MRNA vs NTRA
+507.7%
-471.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | NTRA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.9% | +4.5% | +5.0% |
| 7D | -1.1% | +0.2% | -1.3% | -1.2% |
| 30D | +126.1% | +4.1% | +122.0% | +124.7% |
| 3M | +190.0% | +50.0% | +140.0% | +157.4% |
| 6M | +157.2% | +67.3% | +89.9% | +118.3% |
| YTD | +388.2% | +43.6% | +344.6% | +333.6% |
| 1Y | +467.0% | +89.2% | +377.8% | +364.4% |
| 3Y | +36.1% | +502.5% | -466.5% | -18.2% |
| All | +36.1% | +507.7% | -471.6% | -18.2% |
Cumulative growth
Daily Returns
Daily percentage return beside NTRA.
Daily Out/Under-Performance
Portfolio return minus NTRA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × NTRA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded NTRA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling